1. February 7, 2022

    Don't forget the online form to report suspected side effects of animal treatments

    In juni 2021 lanceerde het FAGG een praktisch en gebruiksvriendelijk onlineformulier waarmee iedereen vermoedelijke bijwerkingen (zowel bij mens als dier) van behandelingen bij dieren kan melden. 

    En juin 2021, l’AFMPS a lancé un formulaire en ligne, pratique et facile à utiliser, grâce auquel chacun peut notifier des effets indésirables présumés (tant chez l’homme que chez l’animal) de traitements pour les animaux. 

    Source: FAMHP

    Read more

  2. February 3, 2022

    New European rules on medicinal products for veterinary use as of 28 January 2022

    As of 28 January 2022, Regulation 2019/6 became effective. From that moment onwards, European Member States must comply with all rules from this regulation.

    Source: FAMHP

    Read more

  3. January 31, 2022

    Coronavirus: monthly update of COVID-19 vaccines 27 January 2022

    Coronavirus: maandelijks overzicht bijwerkingen COVID-19-vaccins van 27 januari 2022

    Coronavirus : aperçu mensuel des effets indésirables des vaccins contre la COVID-19 du 27 janvier 2022

    Source: FAMHP

    Read more

  4. January 31, 2022

    Clinical trials: new European regulation enters into force

    On 31 January 2022, the Clinical Trials Regulation (CTR) 536/2014 on medicinal products for human use will enter into force. However, the old and the new legislation on clinical trials will coexist during a transition period of three years (until 31 January 2025).

    Source: FAMHP

    Read more

  5. January 31, 2022

    EMA: Information session for CTR stakeholders, 3rd February 10h-12h.

    Joint action on support to coordinated and expedited assesment of clinical trials for COVID-19 therapeutics.

    Click here to register.

    Read more

  6. January 21, 2022

    IFAPP Today newsletter - January 2022

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of January 2022.

    Read more

  7. January 20, 2022

    PRAC January 2022 – Review of terlipressin medicines started, update of COVID-19 vaccins and new safety information for Mavenclad

    During its January 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a referral of terlipressin medicines. The PRAC also has recommended a change to the product information for Vaxzevria and COVID-19 Vaccine Janssen. The PRAC discussed direct healthcare professional communication (DHPC) containing important safety information for Mavenclad.

    Source: FAMHP

    Read more

  8. January 20, 2022

    Manufacturers, importers and distributors of human and veterinary medicines must check their data in the Organisation Management Service database of the EMA

    From 28 January 2022, new regulations will come into force for manufacturers, importers and distributors of medicines for human and veterinary use. The FAMHP is asking them to check from 28 January 2022 onwards whether their organisation's data are correctly registered in the Organisation Management Service of the European Medicines Agency (EMA).

    Source: FAMHP

    Read more

  9. January 18, 2022

    Give your opinion on a genetically modified medicine for the treatment of Duchenne muscular dystrophy

    The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial of the genetically modified medicine SRP-9001 for the treatment of Duchenne muscular dystrophy. The public consultation runs from 17 January 2022 to 16 February 2022.

    Source: FAMHP

    Read more

  10. January 13, 2022

    Give your opinion on a genetically modified medicine for the treatment of various types of advanced cancer

    The FPS Public Health and the FAMHP invite you to participate in the public consultation on a clinical trial testing the genetically modified oncolytic virus VSV-GP (BI 1831169), for the treatment of patients with various types of advanced cancer (solid tumours). The public consultation runs from 11 January 2022 to 10 February 2022.

    Source: FAMHP

    Read more